ARTICLE | Company News
XL-protein, Weizmann Institute of Science deal
November 10, 2014 8:00 AM UTC
XL-protein granted Weizmann Institute's Yeda Research and Development Co. Ltd. technology transfer company exclusive, worldwide commercialization rights to preclinical candidate PAS-YNSa8. XL-protein ...